Report copyright - HIGHLIGHTS OF PRESCRIBING INFORMATION …...Valcyte (valganciclovir hydrochloride) for oral solution Initial U.S. Approval: 2001 WARNING: HEMATOLOGIC TOXICITY, CARCINOGENICITY, TERATOGENICITY,
Please pass captcha verification before submit form